NCCN Task Force report

optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines.

George D. Demetri, Robert Benjamin, Charles Blanke, Haesun Choi, Christopher Corless, Ronald P. DeMatteo, Burton L. Eisenberg, Christopher D M Fletcher, Robert G. Maki, Brian P. Rubin, Annick D. Van den Abbeele, Margaret von Mehren, GIST Task Force NCCN GIST Task Force

Research output: Contribution to journalArticle

143 Citations (Scopus)

Abstract

NCCN's Sarcoma Clinical Practice Guidelines in Oncology include a subsection regarding treatment recommendations on gastrointestinal stromal tumors (GISTs). GIST is one area of medicine where the standard of practice has been affected rapidly and dramatically by the introduction of effective molecularly targeted therapy for this disease. There are few examples in modern medicine in which the implementation of new technologies into practice has so radically and rapidly affected clinical diagnostic strategies and treatments with significant implications for the care of patients. Because of these recent changes, NCCN organized a broad multidisciplinary panel composed of experts in the fields of diagnostic radiology, pathology, molecular diagnostics, surgery, medical oncology, and radiation oncology to discuss the optimal approach for the care of patients with GIST at all stages of the disease. The GIST task force is composed of NCCN faculty and other key experts from North America, comprising the United States and Canada. The purpose of this meeting was to expand on the existing NCCN clinical practice guidelines for gastrointestinal sarcomas and to identify areas of future research to optimize our understanding and treatment of this disease.

Original languageEnglish (US)
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume2 Suppl 1
StatePublished - May 2004
Externally publishedYes

Fingerprint

Gastrointestinal Stromal Tumors
Advisory Committees
Practice Guidelines
Sarcoma
Patient Care
Modern 1601-history
Radiation Oncology
Medical Oncology
Molecular Pathology
Therapeutics
North America
Radiology
Canada
Medicine
Pathology
Technology

ASJC Scopus subject areas

  • Oncology

Cite this

NCCN Task Force report : optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines. / Demetri, George D.; Benjamin, Robert; Blanke, Charles; Choi, Haesun; Corless, Christopher; DeMatteo, Ronald P.; Eisenberg, Burton L.; Fletcher, Christopher D M; Maki, Robert G.; Rubin, Brian P.; Van den Abbeele, Annick D.; von Mehren, Margaret; NCCN GIST Task Force, GIST Task Force.

In: Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 2 Suppl 1, 05.2004.

Research output: Contribution to journalArticle

Demetri, GD, Benjamin, R, Blanke, C, Choi, H, Corless, C, DeMatteo, RP, Eisenberg, BL, Fletcher, CDM, Maki, RG, Rubin, BP, Van den Abbeele, AD, von Mehren, M & NCCN GIST Task Force, GISTTF 2004, 'NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines.', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 2 Suppl 1.
Demetri, George D. ; Benjamin, Robert ; Blanke, Charles ; Choi, Haesun ; Corless, Christopher ; DeMatteo, Ronald P. ; Eisenberg, Burton L. ; Fletcher, Christopher D M ; Maki, Robert G. ; Rubin, Brian P. ; Van den Abbeele, Annick D. ; von Mehren, Margaret ; NCCN GIST Task Force, GIST Task Force. / NCCN Task Force report : optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines. In: Journal of the National Comprehensive Cancer Network : JNCCN. 2004 ; Vol. 2 Suppl 1.
@article{87da791dc4444a9aa94a9cbfbb918f69,
title = "NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines.",
abstract = "NCCN's Sarcoma Clinical Practice Guidelines in Oncology include a subsection regarding treatment recommendations on gastrointestinal stromal tumors (GISTs). GIST is one area of medicine where the standard of practice has been affected rapidly and dramatically by the introduction of effective molecularly targeted therapy for this disease. There are few examples in modern medicine in which the implementation of new technologies into practice has so radically and rapidly affected clinical diagnostic strategies and treatments with significant implications for the care of patients. Because of these recent changes, NCCN organized a broad multidisciplinary panel composed of experts in the fields of diagnostic radiology, pathology, molecular diagnostics, surgery, medical oncology, and radiation oncology to discuss the optimal approach for the care of patients with GIST at all stages of the disease. The GIST task force is composed of NCCN faculty and other key experts from North America, comprising the United States and Canada. The purpose of this meeting was to expand on the existing NCCN clinical practice guidelines for gastrointestinal sarcomas and to identify areas of future research to optimize our understanding and treatment of this disease.",
author = "Demetri, {George D.} and Robert Benjamin and Charles Blanke and Haesun Choi and Christopher Corless and DeMatteo, {Ronald P.} and Eisenberg, {Burton L.} and Fletcher, {Christopher D M} and Maki, {Robert G.} and Rubin, {Brian P.} and {Van den Abbeele}, {Annick D.} and {von Mehren}, Margaret and {NCCN GIST Task Force}, {GIST Task Force}",
year = "2004",
month = "5",
language = "English (US)",
volume = "2 Suppl 1",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",

}

TY - JOUR

T1 - NCCN Task Force report

T2 - optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines.

AU - Demetri, George D.

AU - Benjamin, Robert

AU - Blanke, Charles

AU - Choi, Haesun

AU - Corless, Christopher

AU - DeMatteo, Ronald P.

AU - Eisenberg, Burton L.

AU - Fletcher, Christopher D M

AU - Maki, Robert G.

AU - Rubin, Brian P.

AU - Van den Abbeele, Annick D.

AU - von Mehren, Margaret

AU - NCCN GIST Task Force, GIST Task Force

PY - 2004/5

Y1 - 2004/5

N2 - NCCN's Sarcoma Clinical Practice Guidelines in Oncology include a subsection regarding treatment recommendations on gastrointestinal stromal tumors (GISTs). GIST is one area of medicine where the standard of practice has been affected rapidly and dramatically by the introduction of effective molecularly targeted therapy for this disease. There are few examples in modern medicine in which the implementation of new technologies into practice has so radically and rapidly affected clinical diagnostic strategies and treatments with significant implications for the care of patients. Because of these recent changes, NCCN organized a broad multidisciplinary panel composed of experts in the fields of diagnostic radiology, pathology, molecular diagnostics, surgery, medical oncology, and radiation oncology to discuss the optimal approach for the care of patients with GIST at all stages of the disease. The GIST task force is composed of NCCN faculty and other key experts from North America, comprising the United States and Canada. The purpose of this meeting was to expand on the existing NCCN clinical practice guidelines for gastrointestinal sarcomas and to identify areas of future research to optimize our understanding and treatment of this disease.

AB - NCCN's Sarcoma Clinical Practice Guidelines in Oncology include a subsection regarding treatment recommendations on gastrointestinal stromal tumors (GISTs). GIST is one area of medicine where the standard of practice has been affected rapidly and dramatically by the introduction of effective molecularly targeted therapy for this disease. There are few examples in modern medicine in which the implementation of new technologies into practice has so radically and rapidly affected clinical diagnostic strategies and treatments with significant implications for the care of patients. Because of these recent changes, NCCN organized a broad multidisciplinary panel composed of experts in the fields of diagnostic radiology, pathology, molecular diagnostics, surgery, medical oncology, and radiation oncology to discuss the optimal approach for the care of patients with GIST at all stages of the disease. The GIST task force is composed of NCCN faculty and other key experts from North America, comprising the United States and Canada. The purpose of this meeting was to expand on the existing NCCN clinical practice guidelines for gastrointestinal sarcomas and to identify areas of future research to optimize our understanding and treatment of this disease.

UR - http://www.scopus.com/inward/record.url?scp=84879133032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879133032&partnerID=8YFLogxK

M3 - Article

VL - 2 Suppl 1

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

ER -